Skip to main content
FinSpry Logo
FinSpry
TXG logo
TXG
(NASDAQ)
10x Genomics, Inc.
$22.33-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

10x Genomics (TXG) Stock Price & Financial Analysis

10x Genomics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$21.11 - $22.91
52-Week High$23.56
52-Week Low$6.78
Open$21.40
Volume1.28M
Average Volume (3M)1.28M
Market Cap2.84B
Shares Outstanding127.08M
Price to Sales (P/S)4.36
Price to Book (P/B)3.52
EV/EBITDA36.28
Revenue (TTM)642.82M
Net Income (TTM)-43.54M
Free Cash Flow (TTM)130.12M
EPS (TTM)$-0.34
Profit Margin-6.77%
Operating Margin-17.25%
Return on Equity (ROE)-5.47%
Debt to Equity0.11
50-Day MA$20.05
200-Day MA$15.77
52-Week Change154.33%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About 10x Genomics

What is the current stock price for TXG?

As of the latest trading session, TXG stock trades at $22.33. The 52-week range is $6.78–$23.56, with a day range of $21.11–$22.91.

What is the P/E ratio for TXG?

The P/E ratio (Price-to-Earnings) for TXG is shown in the Key Statistics section. This valuation metric helps compare 10x Genomics, Inc. to industry peers.

Does TXG pay dividends?

10x Genomics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TXG?

Based on 5 analysts, the consensus for TXG is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TXG?

10x Genomics's market capitalization is $2.84B, classifying it as a mid-cap company. 10x Genomics operates in the Healthcare sector within the Health Information Services industry.